Finance

Lists
603739:SHA
Qingdao Vland Biotech INC
CN¥12,76
+0,71%
(+0,090) 1D
16 Okt., 11:30:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603739...
Open
CN¥12,80
High
CN¥13,04
Low
CN¥12,56
Mkt. cap
3,33 mjd
Avg. vol.
6,62 m
Volume
4,44 m
Dividend
0,78%
Quarterly dividend
CN¥0,02
Ex-dividend date
29 Mei 2026
P/E ratio
39,54
52-wk high
CN¥18,41
52-wk low
CN¥10,68
EPS
CN¥0,32
No. of employees
2 k
Open
CN¥12,80
High
CN¥13,04
Low
CN¥12,56
Mkt. cap
3,33 mjd
Avg. vol.
6,62 m
Volume
4,44 m
Dividend
0,78%
Quarterly dividend
CN¥0,02
Ex-dividend date
29 Mei 2026
P/E ratio
39,54
52-wk high
CN¥18,41
52-wk low
CN¥10,68
EPS
CN¥0,32
No. of employees
2 k
News stories
From web sources and news partners
About Qingdao Vland Biotech INC
CEO-
Employees1,52 k
Founded23 Feb. 2005
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
363,60 m
350,33 m
345,05 m
364,57 m
Cost of goods sold
206,93 m
196,37 m
192,44 m
205,47 m
Cost of revenue
206,93 m
196,37 m
192,44 m
205,47 m
Research and development expenses
36,36 m
38,97 m
30,17 m
31,87 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84,53 m
94,78 m
87,70 m
91,50 m
Operating expense
110,42 m
161,80 m
124,11 m
129,75 m
Total operating expenses
317,34 m
358,18 m
316,55 m
335,22 m
Operating income
46,26 m
-7,84 m
28,50 m
29,35 m
Other non operating income
439,18 k
-226,95 k
584,70 k
-1,93 m
EBT including unusual items
55,31 m
15,32 m
32,23 m
36,61 m
EBT excluding unusual items
42,98 m
-14,43 m
26,98 m
21,44 m
Income tax expense
12,18 m
786,41 k
6,78 m
8,72 m
Effective tax rate
22,03%
5,13%
21,03%
23,83%
Other operating expenses
-16,77 m
24,95 m
4,07 m
4,20 m
Net income
35,06 m
8,03 m
17,87 m
20,69 m
Net profit margin
9,64%
2,29%
5,18%
5,68%
Earnings per share
-
-
-
-
Interest and investment income
161,61 k
177,29 k
3,32 m
-
Interest expense
-3,83 m
-5,59 m
-5,42 m
-4,46 m
Net interest expenses
-3,67 m
-5,41 m
-2,11 m
-4,46 m
Depreciation and amortization charges
-
-
-
-
EBITDA
73,86 m
21,14 m
57,49 m
56,49 m
Gain or loss from assets sale
393,28 k
-470,74 k
-
-40,68 k
AI content may include mistakes. Learn more
Google-programme